The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma biomarker study of lenvatinib in gastroenteropancreatic neuroendocrine tumors reveals Ang2 and FGF2 as predictors of treatment response: Results from the international phase II TALENT trial (GETNE 1509).
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Gabriela Jimenez-Valerio
No Relationships to Disclose
 
Alba Martinez
No Relationships to Disclose
 
Jorge Hernando
Speakers' Bureau - Advanced Accelerator Applications; Angelini Pharma; Eisai; Ipsen; Roche
Travel, Accommodations, Expenses - Advanced Accelerator Applications; AstraZeneca; Eisai; Ipsen; Novartis; Roche
 
Toni Ibrahim
Consulting or Advisory Role - Eisai; Novartis (Inst); Sanofi
Travel, Accommodations, Expenses - Ipsen; Novartis; Pharmamar
 
Nicola Fazio
Honoraria - Advanced Accelerator Applications; Ipsen; Merck; Novartis; Sanofi
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Merck Serono; MSD Oncology; Novartis/Ipsen; Pfizer
Research Funding - Ipsen (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst)
Other Relationship - Il Pensiero Scientifico Editore; Springer
 
Carlos Lopez
No Relationships to Disclose
 
Alex Teule
Honoraria - AAA HealthCare; Ipsen; Novartis; Pfizer
Consulting or Advisory Role - AAA HealthCare
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; Aptitude Health; AstraZeneca; Baxter; Debiopharm Group; Genoscience Pharma; Hutchison MediPharma; Imaging Equipment Limited; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; Nucana; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics; SERVIER; Sirtex Medical; Wren Laboratories; Zymeworks
Speakers' Bureau - Imaging Equipment Limited; Incyte; Ipsen; Mylan; Novartis; Nucana
Travel, Accommodations, Expenses - Lilly; Nucana; Pfizer
 
Salvatore Tafuto
No Relationships to Disclose
 
Ana B. Custodio
No Relationships to Disclose
 
Nicholas Simon Reed
Honoraria - Eisai; Ipsen; Lilly; Lilly; Novartis; Roche
Consulting or Advisory Role - Eisai; Ipsen; Novartis
Speakers' Bureau - Roche
Research Funding - Exelixis (Inst); Ipsen (Inst); Lilly (Inst); Novartis (Inst)
 
Markus Raderer
No Relationships to Disclose
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; EUSA Pharma; Eusa Pharma; Genzyme; IPSEN; Janssen-Cilag; Lexicon; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD; Pfizer; Roche; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ipsen (Inst); Lexicon (Inst); Molecular Templates (Inst); Pfizer (Inst); Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Pfizer; Roche/Genentech
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; Advanz Pharma; AstraZeneca (I); Bayer; Boehringer Ingelheim (I); Bristol-Myers Squibb (I); Gilead Sciences (I); HMP; Ipsen; Lilly (I); MERCK; Merck (I); Midatech Pharma; MSD; NOVARTIS; PFIZER; PharmaMar; PharmaMar (I); Pierre Fabre; ROCHE; Roche (I); Sanofi; SERVIER; SERVIER (I); Sysmex (I)
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; HMP; Ipsen; Merck; MSD; Novartis; Pfizer; PharmaMar; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; Roche
 
Paula Jiménez-Fonseca
Other Relationship - IPSEN
 
Vicente Alonso
Consulting or Advisory Role - Amgen; Ipsen; Merck Serono; Sanofi/Regeneron; SERVIER
Travel, Accommodations, Expenses - Amgen; Ipsen; Merck Serono; Novartis; Roche; Sanofi/Regeneron; SERVIER
 
Oriol Casanovas
Patents, Royalties, Other Intellectual Property - Patents pending